Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort

被引：0
|
作者：
Pamela L. Horn-Ross
Alison J. Canchola
Leslie Bernstein
Susan L. Neuhausen
David O. Nelson
Peggy Reynolds
机构：
[1] Cancer Prevention Institute of California,Department of Population Sciences
[2] Cancer Prevention Institute of California,Division of Epidemiology, Department of Health Research and Policy
[3] Beckman Research Institute,undefined
[4] City of Hope,undefined
[5] Stanford University School of Medicine,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Breast cancer; Body size; Obesity; Adiposity; Body fat distribution; Height; Life course;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers
    Nath, Aritro
    Cohen, Adam L.
    Bild, Andrea H.
    MOLECULAR SYSTEMS BIOLOGY, 2022, 18 (06)
  • [42] ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
    Xu, Guotai
    Chhangawala, Sagar
    Cocco, Emiliano
    Razavi, Pedram
    Cai, Yanyan
    Otto, Jordan E.
    Ferrando, Lorenzo
    Selenica, Pier
    Ladewig, Erik
    Chan, Carmen
    Paula, Arnaud Da Cruz
    Witkin, Matthew
    Cheng, Yuanming
    Park, Jane
    Serna-Tamayo, Cristian
    Zhao, HuiYong
    Wu, Fan
    Sallaku, Mirna
    Qu, Xuan
    Zhao, Alison
    Collings, Clayton K.
    D'Avino, Andrew R.
    Jhaveri, Komal
    Koche, Richard
    Levine, Ross L.
    Reis-Filho, Jorge S.
    Kadoch, Cigall
    Scaltriti, Maurizio
    Leslie, Christina S.
    Baselga, Jose
    Toska, Eneda
    NATURE GENETICS, 2020, 52 (02) : 198 - +
  • [43] Body size and breast cancer risk: The multiethnic cohort
    White, Kami K.
    Park, Song-Yi
    Kolonel, Laurence N.
    Henderson, Brian E.
    Wilkens, Lynne R.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : E705 - E716
  • [44] Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
    Miller, Christopher A.
    Gindin, Yevgeniy
    Lu, Charles
    Griffith, Obi L.
    Griffith, Malachi
    Shen, Dong
    Hoog, Jeremy
    Li, Tiandao
    Larson, David E.
    Watson, Mark
    Davies, Sherri R.
    Hunt, Kelly
    Suman, Vera J.
    Snider, Jacqueline
    Walsh, Thomas
    Colditz, Graham A.
    DeSchryver, Katherine
    Wilson, Richard K.
    Mardis, Elaine R.
    Ellis, Matthew J.
    Nature Communications, 2016, 7
  • [45] Radiation Without Endocrine Therapy in Older Women With Stage I Estrogen-Receptor-Positive Breast Cancer is Not Associated With a Higher Risk of Second Breast Cancer Events
    Gerber, Naamit K.
    Shao, Huibo
    Chadha, Manjeet
    Deb, Partha
    Gold, Heather T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (01): : 40 - 51
  • [46] Meta analysis of the second collaborative study of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) in patients with stage II, estrogen-receptor-positive breast cancer
    Yoshida M.
    Abe O.
    Uchino J.
    Kikuchi K.
    Abe R.
    Enomoto K.
    Tominaga T.
    Fukami A.
    Sugimachi K.
    Nomura Y.
    Hattori T.
    Ogawa N.
    Breast Cancer, 1997, 4 (2) : 93 - 101
  • [47] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [48] Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer (vol 12, 599586, 2021)
    Belachew, Esmael Besufikad
    Sewasew, Dareskedar Tsehay
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [49] Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
    Christopher A. Miller
    Yevgeniy Gindin
    Charles Lu
    Obi L Griffith
    Malachi Griffith
    Dong Shen
    Jeremy Hoog
    Tiandao Li
    David E. Larson
    Mark Watson
    Sherri R Davies
    Kelly Hunt
    Vera J. Suman
    Jacqueline Snider
    Thomas Walsh
    Graham A. Colditz
    Katherine DeSchryver
    Richard K. Wilson
    Elaine R. Mardis
    Matthew J. Ellis
    Nature Communications, 7
  • [50] Vessel size as a marker of survival in estrogen receptor positive breast cancer
    Vladan Milosevic
    Reidunn J. Edelmann
    Ingeborg Winge
    Carina Strell
    Artur Mezheyeuski
    Gøril Knutsvik
    Cecilie Askeland
    Elisabeth Wik
    Lars A. Akslen
    Arne Östman
    Breast Cancer Research and Treatment, 2023, 200 : 293 - 304
12345